Show simple item record

dc.contributor.authorWu, Xiaoke
dc.contributor.authorYu, Kaijiang
dc.contributor.authorWang, Yongchen
dc.contributor.authorXu, Wanhai
dc.contributor.authorMa, Hongli
dc.contributor.authorHou, Yan
dc.contributor.authorLi, Yue
dc.contributor.authorCai, Benzhi
dc.contributor.authorZhu, Liying
dc.contributor.authorZhang, Min
dc.contributor.authorHu, Xiaoli
dc.contributor.authorGao, Jingshu
dc.contributor.authorWang, Yu
dc.contributor.authorQin, Huichao
dc.contributor.authorWang, Wenjie
dc.contributor.authorZhao, Mingyan
dc.contributor.authorWu, Xia
dc.contributor.authorZhang, Yong
dc.contributor.authorLi, Lu
dc.contributor.authorLi, Kang
dc.contributor.authorDu, Zhimin
dc.contributor.authorMol, Ben Willem J
dc.contributor.authorYang, Baofeng
dc.date.accessioned2021-04-02T12:56:01Z
dc.date.available2021-04-02T12:56:01Z
dc.date.issued2020-10
dc.identifier.citationWu , X , Yu , K , Wang , Y , Xu , W , Ma , H , Hou , Y , Li , Y , Cai , B , Zhu , L , Zhang , M , Hu , X , Gao , J , Wang , Y , Qin , H , Wang , W , Zhao , M , Wu , X , Zhang , Y , Li , L , Li , K , Du , Z , Mol , B W J & Yang , B 2020 , ' Efficacy and safety of triazavirin therapy for coronavirus disease 2019 : A pilot randomized controlled trial ' , Engineering (Beijing, China) , vol. 6 , no. 10 , pp. 1185-1191 . https://doi.org/10.1016/j.eng.2020.08.011en
dc.identifier.issn2095-8099
dc.identifier.otherPURE: 176213645
dc.identifier.otherPURE UUID: b9506c66-7a93-4df0-be3b-81187459b66d
dc.identifier.otherPubMed: 32923016
dc.identifier.otherPubMedCentral: PMC7476906
dc.identifier.otherScopus: 85091712049
dc.identifier.urihttps://hdl.handle.net/2164/16182
dc.descriptionAcknowledgements: We are deeply grateful to the front-line clinicians who participated in the study while directly fighting the epidemic. This study was supported by the Chinese Academy of Engineering Projects for COVID-19 (2020-KYGG-01-04) and Heilongjiang Province Urgent Project-6 for COVID-19. Data and safety monitoring board members of this trial included Kang Li, Yong Zhang, Songjiang Liu, and Yaohui Shi.en
dc.format.extent7
dc.language.isoeng
dc.relation.ispartofEngineering (Beijing, China)en
dc.rights©2020 THE AUTHORS. Published by Elsevier LTD on behalf of Chinese Academy of Engineering and Higher Education Press Limited Company.This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).en
dc.subjectCoronavirus disease 2019en
dc.subjectTriazavirinen
dc.subjectEfficacyen
dc.subjectSafetyen
dc.subjectR Medicineen
dc.subjectEngineering(all)en
dc.subjectEnergy Engineering and Power Technologyen
dc.subjectChemical Engineering(all)en
dc.subjectComputer Science(all)en
dc.subjectEnvironmental Engineeringen
dc.subjectMaterials Science (miscellaneous)en
dc.subject.lccRen
dc.titleEfficacy and safety of triazavirin therapy for coronavirus disease 2019 : A pilot randomized controlled trialen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1016/j.eng.2020.08.011
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85091712049&partnerID=8YFLogxKen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record